Organigram Global (OGI) Retained Earnings (2018 - 2026)
Organigram Global (OGI) posted quarterly Retained Earnings of -$430.0 million for Q1 2026, down 1.85% on a QoQ basis from -$422.2 million in Q4 2025.
Organigram Global (OGI) Retained Earnings (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Retained Earnings for 9 consecutive years, with -$430.0 million the latest figure, recorded in Q1 2026.
- Quarterly Retained Earnings changed N/A year-over-year to -$430.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$430.0 million (changed N/A YoY) and the FY2025 annual result came in at -$422.2 million, changed N/A from the prior year.
- Retained Earnings fell to -$430.0 million in Q1 2026 per OGI's latest filing, from -$422.2 million in the prior quarter.
- Over the last five years, Retained Earnings for OGI reached as high as -$46182.4 in Q3 2024 and fell as low as -$442.3 million in Q3 2025.
- A 5-year average of -$320.2 million and a median of -$411.9 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings jumped 99.99% — and 2025, when it slumped 957673.27%.
- Year by year, Retained Earnings stood at -$225.1 million in 2022, then slumped by 78.43% to -$401.7 million in 2023, then soared by 99.99% to -$46182.4 in 2024, then sank by 914080.74% to -$422.2 million in 2025, then dropped by 1.85% to -$430.0 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$430.0 million, -$422.2 million, and -$442.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | -430.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -430.00 Mn |
| Dec 31, 2025 | -422.19 Mn |
| Sep 30, 2025 | -442.32 Mn |
| Sep 30, 2024 | -46,182.36 |
| Sep 30, 2023 | -401.70 Mn |
| Aug 31, 2022 | -225.13 Mn |
| Nov 30, 2021 | -276.95 Mn |
| Aug 31, 2021 | -275.64 Mn |
| May 31, 2021 | -249.67 Mn |
| Feb 28, 2021 | -245.67 Mn |
| Nov 30, 2020 | -179.28 Mn |
| Aug 31, 2020 | 37,208.64 |
| May 31, 2020 | -76.05 Mn |
| Feb 29, 2020 | -16.48 Mn |
| Aug 31, 2019 | -32,524.97 |
| May 31, 2019 | 34,000.00 |
| Aug 31, 2018 | 579,693.72 |